<html>
<head>PUBMED IDs for RNU48</head>
<body bgcolor='#C5F0F2'><h1>RNU48</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18718003/'>Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer.</a> August 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18717994/'>Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.</a> August 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18717985/'>Comparison of prognostic gene expression signatures for breast cancer.</a> August 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21370248/'>Induction of MiR-17-3p and MiR-106a [corrected] by TNFÎ± and LPS.</a> June 21  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21412770/'>Evaluation and identification of reliable reference genes for pharmacogenomics, toxicogenomics, and small RNA expression analysis.</a> October 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21741950/'>Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22643910/'>MicroRNA detection in prostate tumors by quantitative real-time PCR (qPCR).</a> August 14  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22909992/'>Screening and confirmation of microRNA markers for forensic body fluid identification.</a> May 8  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24223986/'>A combination of Let-7d, Let-7g and Let-7i serves as a stable reference for normalization of serum microRNAs.</a> August 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/27889881/'>Identification of reference genes and miRNAs for qRT-PCR in human esophageal squamous cell carcinoma.</a> March 18  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27920004/'>Down-regulation of MicroRNA-126 in Glioblastoma and its Correlation with Patient Prognosis: A Pilot Study.</a> January 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27919976/'>Phase I Study of Triweekly Nab-Paclitaxel Combined with S-1 in Patients with HER2-negative Metastatic Breast Cancer.</a> January 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27919966/'>Multimodal Primary Treatment of Metastatic Prostate Cancer with Androgen Deprivation and Radiation.</a> January 31  2016<br></body></html>
